Can-Fite BioPharma Ltd.CANFNYSE
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank50
3Y CAGR-12.9%
5Y CAGR+29.8%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-12.9%/yr
vs -2.7%/yr prior
5Y CAGR
+29.8%/yr
Recent deceleration
Acceleration
-10.2pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
3.7x
Strong expansion
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 50502.81 | +31.7% |
| 2023 | 38341.99 | -39.7% |
| 2022 | 63533.71 | -16.8% |
| 2021 | 76343.21 | -8.1% |
| 2020 | 83096.27 | +506.1% |
| 2019 | 13709.74 | -27.6% |
| 2018 | 18941.24 | -77.7% |
| 2017 | 85124.60 | -85.7% |
| 2016 | 593374.89 | -3.8% |
| 2015 | 616604.60 | - |